Major Clinical Trials 2000

UKMi Central Clinical Trials Section

Please make a selection from the options below

Clinical trials database

Major Clinical Trials, Reviews and Meta-analyses published
2000 / 2004

Clinical trial synonyms

Clinical trial notes

Short critiques of major clinical trials

New Critiques

Title	Reference
ACCOMPLISH Study
ACTIVE-A Trial	N Engl J Med 2009; 360: published early online March 31, 2009
ACTIVE W Trial	Lancet 2006; 367:1903-12
ADOPT Study	N Engl J Med 2006; 355:2427-43
ADVANCE Trial	Lancet 8 Sep 2007; 370:829-840
ADVANCE2 Trial	N Engl J Med 2008; 358: 2560-72
Anticholinergics in COPD	J Gen Intern Med 2006;21:1011-19
Antidepressant effectiveness	PLoS Medicine 2008 (February); 5(2):e45
Asthma deaths with beta agonists	Ann Intern Med 2006; 144:904-12
BIG 1-98 Study	N Engl J Med 2005; 353: 2747-57
CHARISMA Study (revision)	N Engl J Med 2006; 354: 1706-17
Deaths with long-acting beta agonists	Ann Intern Med 2006;144:904-12
DiGEM Trial
Dimeticone vs malathion for head lice	PLoS ONE 2007; 2 (11): e1127
ESPRIT Trial	Lancet 2006; 367:1665-73
GISSI-HF trial	Lancet early online
Glucose Self-Monitoring	Diabetes Care 2005; 28: 1510-17
HORIZON Trial	N Engl J Med 2007; 357:1799-809
INSPIRE Study	Am J Resp Crit Care Med 2008; 177:19-26
The IDEAL Study	JAMA 2005; 294: 2437-45
The JUPITER Study	New Engl J Med 2008; 359: 2195-
POET-COPD study	N Engl J Med 2011;364:1093-1103
The PROactive Study	Lancet 2005; 366:1279-89
RIO-Diabetes	Lancet 2006; 368:1660-72
The RUTH and STAR Trials of raloxifene	N Engl J Med 2006;355:125-37; JAMA 2006;295:2727-41
SAGE Study	Circulation 2007;115:700-707
SANAD Studies	Lancet 2007; 369:1000-15; ibid 1016-26
SPARCL Study	N Engl J Med 2006; 355:549-59
SHIFT Study	Lancet: published online August 29, 2010
Tiotropium combinations for COPD	Ann Intern Med 2007; 146: published early online 20/2/07
TORCH Study	New Engl J Med 2007;356:775-89
UPLIFT Trial	N Engl J Med 2008; 359:1543-54
UPLIFT Trial
VADT Study	N Engl J Med 2009; 360:129-39

Archive

About the Author

These critiques have been submitted by Peter Burrill, Specialist in Pharmaceutical Public Health, North Derbyshire Public Health Network. They are on the website as a resource for other health professionals. They represent the views of the author and not necessarily those of the Medicines Information Service or the pharmaceutical companies of the drugs involved . Any queries on these critiques will be forwarded to the author.